Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04154423 · ClinicalTrials.gov registry record · NA
Engaging Mothers & Babies; Reimagining Antenatal Care for Everyone (EMBRACE) Study
A NA study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 674
- Enrollment target
NCT04154423: Completed NA study, sponsored by University of California, San Francisco.
NCT04154423 is a NA study that has completed, run by University of California, San Francisco. The registered enrollment target is 674 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (52% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04154423, a NA study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 674 participants
- Enrollment target
Study Summary
This is a randomized comparative effectiveness study of two forms of enhanced prenatal care among 657 Medi-Cal eligible pregnant individuals in Fresno, California. The goal is to see whether group prenatal care with wrap around services versus individual prenatal care supplemented by services covered by the California Department of Public Health Comprehensive Perinatal Services Program (CPSP) results in less depression and anxiety, and more respectful, more person-centered maternity care and lower rates of preterm birth.
Primary Outcome
Changes in depressive symptom severity from baseline to postpartum. Assessed using the Patient Health Questionnaire (PHQ-9), administered in-person at baseline and during telephone interview at three months postpartum. Total score ranges from 0-27 with higher scores indicating more severe depression.
Interventions
- OTHER Glow! Group Prenatal Care
- OTHER Individual Prenatal Care with CPSP
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 674 participants |
| Start Date | 2019-11-07 |
| Est. Completion | 2024-12-23 |
| Phase | NA |
What the finished NCT04154423 record still lists
NCT04154423 is an interventional study that assigns participants to a tested intervention. The registered 674 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (52% lower).
The record links to 0 conditions, and to 2 interventions - of which Glow! Group Prenatal Care is the first listed.
NCT04154423 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04154423 about?
NCT04154423 is a clinical study titled "Engaging Mothers & Babies; Reimagining Antenatal Care for Everyone (EMBRACE) Study". This is a randomized comparative effectiveness study of two forms of enhanced prenatal care among 657 Medi-Cal eligible pregnant individuals in Fresno, California. The goal is to see whether group prenatal care with wrap around services versus individual prenatal care supplemented by services covere...
What is the current status of trial NCT04154423?
This trial is currently completed. It is a NA study. The enrollment target is 674 participants. The study started on 2019-11-07. Estimated completion is 2024-12-23.
What interventions are being tested in trial NCT04154423?
The interventions under investigation include: Glow! Group Prenatal Care (OTHER), Individual Prenatal Care with CPSP (OTHER).
Who is sponsoring clinical trial NCT04154423?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04154423's enrollment target sits among peer trials
674 151st of 2000 higher than 1,850 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06335381 · 674 participants · NA
MOMs Chat and Care Study
- NCT06757634 · 674 participants · Phase 3
Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)
- NCT04788277 · 675 participants
Investigation Into Detection of Prostate Cancer Using Voided Urine (Prostate VPAC)
- NCT05356234 · 675 participants · NA
Ignite Study of the Jewish Family and Children's Service of the Suncoast, Inc.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI